1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Safinamide
Trade Name:
Onstryv
Manufacturer/Distributor:
Valeo Pharma Inc.
Classification:
Monoamine oxidase B inhibitor
ATC Class:
N04BD03 - safinamide
Status:
active
Notice of Compliance (yyyy/mm/dd):
2019/01/10
Date Marketed in Canada (yyyy/mm/dd):
2019/07/10
Presentation:
Tablet: 50 mg. DIN: 02484641
Tablet: 100 mg. DIN: 02484668
Comments:
Add-on therapy for patients with Parkinson’s disease who are already on levodopa.
Safinamide is a highly selective and reversible inhibitor of monoamine oxidase B (MAO-B). By blocking catabolism of dopamine, inhibition of MAO-B is thought to increase extracellular levels of dopamine in the striatum and subsequently increase dopaminergic activity.
Source:
Product monograph
Back to:
Drug Product Listings 
